Bloodstream Infection Testing Market - Global Forecast 2025-2032

The bloodstream infection testing market is a focal point in clinical diagnostics, as healthcare leaders seek solutions that balance diagnostic precision with operational efficiency. Rapid industry transformation is prompting a shift toward integrated technologies and streamlined workflows to enhance infection management outcomes.

Market Snapshot: Bloodstream Infection Testing Market Overview

The bloodstream infection testing market expanded from USD 1.20 billion in 2024 to USD 1.30 billion in 2025, with a projected compound annual growth rate (CAGR) of 7.93% that is expected to reach USD 2.22 billion by 2032. This strong upward trend is fueled by continual advancements in diagnostic platforms, making high-value infection detection accessible within clinical, laboratory, and public health environments worldwide. Healthcare organizations are rapidly integrating new technologies to strengthen infection control, optimize patient care, and align with global health quality initiatives. Strategic investments and innovations are being seen across regions and care delivery models, as market participants respond to increasing demands for efficient and precise diagnostic solutions.

Scope & Segmentation

This report provides actionable insights into bloodstream infection testing workflows, delivering a detailed segmentation to support informed strategic planning:

• Product: Includes instruments, reagents and kits, and software—designed to support evolving diagnostic needs and drive operational efficiencies in clinical laboratories.
• Technology: Covers biosensor platforms such as electrochemical and optical biosensors; culture-based systems leveraging both automated and manual techniques; mass spectrometry solutions, including MALDI ToF MS; and molecular diagnostics like PCR and next-generation sequencing. Each technology’s role in delivering rapid and accurate infection detection is evaluated.
• End User: Encompasses academic and research institutes, hospital laboratories, point-of-care testing facilities, and reference laboratories. This captures the varied landscape of clinical applications and organizational requirements.
• Application: Focuses on clinical diagnosis, research, surveillance, and monitoring—reflecting both established and emerging use cases for bloodstream infection testing.
• Region: Examines markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, providing relevant country-level insights for both established and emerging economies handling infection diagnostics.
• Key Companies: Highlights major participants, including Becton Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., Luminex Corporation, and QIAGEN N.V.

Key Takeaways for Decision-Makers

• Rising pathogen and antibiotic resistance is shaping diagnostic stewardship, underscoring the need for timely and accurate detection methods to positively impact clinical decisions and outcomes.
• Molecular diagnostics and biosensor-based solutions are transforming laboratory operations, facilitating faster and more decentralized infection testing for both centralized facilities and remote settings.
• Mass spectrometry and digital technologies are broadening the range of pathogen detection. These innovations also provide improved data management and facilitate better coordination across healthcare systems.
• Hospitals and point-of-care providers are leveraging advanced technology and collaborations to streamline diagnostic pathways, enhancing both patient management and resource allocation.
• Variations in regional reimbursement structures, regulatory requirements, and laboratory capabilities influence technology uptake, guiding companies to develop regionally responsive market entry and scale strategies.
• Industry leaders are integrating artificial intelligence, cloud-based solutions, and new partnerships to improve workflow efficiency and maintain competitive positioning within the evolving diagnostics environment.

Tariff Impact

Recent tariff changes in the United States targeting diagnostic reagents and instruments have added complexity to the bloodstream infection testing supply chain. Healthcare providers are updating procurement strategies and building adaptive supplier partnerships to weather increased cost pressures. Common market responses include investing in regional manufacturing, adopting reagent rental models, and negotiating flexible supply contracts to ensure operational continuity and manage costs in a changing regulatory setting.

Methodology & Data Sources

The analysis synthesizes market intelligence from in-depth interviews with laboratory and clinical experts, procurement professionals, and a review of authoritative literature, clinical guidelines, and industry datasets. This robust approach ensures reliable data and clear segmentation, helping executives make confident strategic decisions.

Why This Report Matters

• Aligns diagnostic technology and procurement planning with dynamic clinical, operational, and regulatory needs in the bloodstream infection testing market.
• Supports benchmarking of innovation and partnerships against leading global and regional organizations, enabling sharper organizational positioning and forward-looking strategy development.
• Provides detailed segmentation and granular regional perspectives to optimize resource deployment, supporting more effective decisions for market entry, expansion, or product portfolio adjustments.

Conclusion

Bloodstream infection testing is critical for managing clinical risk and elevating patient care standards. Senior leaders will find the insights in this report essential for shaping effective infection management strategies and differentiating within the diagnostics sector.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.